A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF)-Reference-Cited by-同舟云学术

A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF)

Published:2023-08 Issue: Volume:76 Page:154301
ISSN:0883-9441
Container-title:Journal of Critical Care
language:en
Short-container-title:Journal of Critical Care

Author:

Gatti Milo,Rinaldi Matteo,Gaibani Paolo,Siniscalchi Antonio,Tonetti Tommaso,Giannella Maddalena,Viale Pierluigi,Pea Federico

Funder

European Commission

Ministero dell'Istruzione dell'Universita e della Ricerca

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine

Reference27 articles.

1. Antimicrobial Resistance;Marston;JAMA,2016

2. New β-lactam-β-lactamase inhibitor combinations;Yahav;Clin Microbiol Rev,2020

3. Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

4. Assessment of a PK/PD target of continuous infusion Beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections;Gatti;Antibiotics (Basel),2021

5. Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with Carbapenem-resistant Enterobacteriaceae infections;Shields;Antimicrob Agents Chemother,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosing Evaluation of Ceftazidime–Avibactam in Intensive Care Unit Patients Based on Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling and Simulation;Antibiotics;2024-09-09

2. Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia;European Journal of Clinical Microbiology & Infectious Diseases;2024-07-17

3. Novel Antibiotics for Gram-Negative Nosocomial Pneumonia;Antibiotics;2024-07-05

4. Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

5. Ceftazidime/avibactam serum concentration in patients on ECMO;Journal of Antimicrobial Chemotherapy;2024-03-28